Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis

Standard

Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis. / Banki, Eszter; Fisi, Viktoria; Moser, Sandra; Wengi, Agnieszka; Carrel, Monique; Loffing-Cueni, Dominique; Penton, David; Kratschmar, Denise V; Rizzo, Ludovica; Lienkamp, Soeren; Odermatt, Alex; Rinschen, Markus M; Loffing, Johannes.

in: KIDNEY INT, Jahrgang 100, Nr. 4, 10.2021, S. 850-869.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Banki, E, Fisi, V, Moser, S, Wengi, A, Carrel, M, Loffing-Cueni, D, Penton, D, Kratschmar, DV, Rizzo, L, Lienkamp, S, Odermatt, A, Rinschen, MM & Loffing, J 2021, 'Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis', KIDNEY INT, Jg. 100, Nr. 4, S. 850-869. https://doi.org/10.1016/j.kint.2021.06.030

APA

Banki, E., Fisi, V., Moser, S., Wengi, A., Carrel, M., Loffing-Cueni, D., Penton, D., Kratschmar, D. V., Rizzo, L., Lienkamp, S., Odermatt, A., Rinschen, M. M., & Loffing, J. (2021). Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis. KIDNEY INT, 100(4), 850-869. https://doi.org/10.1016/j.kint.2021.06.030

Vancouver

Bibtex

@article{6efc1b3160a34950ad8b9453c3b5f247,
title = "Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis",
abstract = "Adverse effects of calcineurin inhibitors (CNI), such as hypertension, hyperkalemia, acidosis, hypomagnesemia and hypercalciuria, have been linked to dysfunction of the distal convoluted tubule (DCT). To test this, we generated a mouse model with an inducible DCT-specific deletion of the calcineurin regulatory subunit B alpha (CnB1-KO). Three weeks after CnB1 deletion, these mice exhibited hypomagnesemia and acidosis, but no hypertension, hyperkalemia or hypercalciuria. Consistent with the hypomagnesemia, CnB1-KO mice showed a downregulation of proteins implicated in DCT magnesium transport, including TRPM6, CNNM2, SLC41A3 and parvalbumin but expression of calcium channel TRPV5 in the kidney was unchanged. The abundance of the chloride/bicarbonate exchanger pendrin was increased, likely explaining the acidosis. Plasma aldosterone levels, kidney renin expression, abundance of phosphorylated sodium chloride-cotransporter and abundance of the epithelial sodium channel were similar in control and CnB1-KO mice, consistent with a normal sodium balance. Long-term potassium homeostasis was maintained in CnB1-KO mice, but in-vivo and ex-vivo experiments indicated that CnB1 contributes to acute regulation of potassium balance and sodium chloride-cotransporter. Tacrolimus treatment of control and CnB1-KO mice demonstrated that CNI-related hypomagnesemia is linked to impaired calcineurin-signaling in DCT, while hypocalciuria and hyponatremia occur independently of CnB1 in DCT. Transcriptome and proteome analyses of isolated DCTs demonstrated that CnB1 deletion impacts the expression of several DCT-specific proteins and signaling pathways. Thus, our data support a critical role of calcineurin for DCT function and provide novel insights into the pathophysiology of CNI side effects and involved molecular players in the DCT.",
keywords = "Acidosis, Animals, Calcineurin/genetics, Kidney Tubules, Distal, Magnesium, Mice, Proteome/genetics, Transcriptome",
author = "Eszter Banki and Viktoria Fisi and Sandra Moser and Agnieszka Wengi and Monique Carrel and Dominique Loffing-Cueni and David Penton and Kratschmar, {Denise V} and Ludovica Rizzo and Soeren Lienkamp and Alex Odermatt and Rinschen, {Markus M} and Johannes Loffing",
note = "Copyright {\textcopyright} 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.",
year = "2021",
month = oct,
doi = "10.1016/j.kint.2021.06.030",
language = "English",
volume = "100",
pages = "850--869",
journal = "KIDNEY INT",
issn = "0085-2538",
publisher = "NATURE PUBLISHING GROUP",
number = "4",

}

RIS

TY - JOUR

T1 - Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis

AU - Banki, Eszter

AU - Fisi, Viktoria

AU - Moser, Sandra

AU - Wengi, Agnieszka

AU - Carrel, Monique

AU - Loffing-Cueni, Dominique

AU - Penton, David

AU - Kratschmar, Denise V

AU - Rizzo, Ludovica

AU - Lienkamp, Soeren

AU - Odermatt, Alex

AU - Rinschen, Markus M

AU - Loffing, Johannes

N1 - Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

PY - 2021/10

Y1 - 2021/10

N2 - Adverse effects of calcineurin inhibitors (CNI), such as hypertension, hyperkalemia, acidosis, hypomagnesemia and hypercalciuria, have been linked to dysfunction of the distal convoluted tubule (DCT). To test this, we generated a mouse model with an inducible DCT-specific deletion of the calcineurin regulatory subunit B alpha (CnB1-KO). Three weeks after CnB1 deletion, these mice exhibited hypomagnesemia and acidosis, but no hypertension, hyperkalemia or hypercalciuria. Consistent with the hypomagnesemia, CnB1-KO mice showed a downregulation of proteins implicated in DCT magnesium transport, including TRPM6, CNNM2, SLC41A3 and parvalbumin but expression of calcium channel TRPV5 in the kidney was unchanged. The abundance of the chloride/bicarbonate exchanger pendrin was increased, likely explaining the acidosis. Plasma aldosterone levels, kidney renin expression, abundance of phosphorylated sodium chloride-cotransporter and abundance of the epithelial sodium channel were similar in control and CnB1-KO mice, consistent with a normal sodium balance. Long-term potassium homeostasis was maintained in CnB1-KO mice, but in-vivo and ex-vivo experiments indicated that CnB1 contributes to acute regulation of potassium balance and sodium chloride-cotransporter. Tacrolimus treatment of control and CnB1-KO mice demonstrated that CNI-related hypomagnesemia is linked to impaired calcineurin-signaling in DCT, while hypocalciuria and hyponatremia occur independently of CnB1 in DCT. Transcriptome and proteome analyses of isolated DCTs demonstrated that CnB1 deletion impacts the expression of several DCT-specific proteins and signaling pathways. Thus, our data support a critical role of calcineurin for DCT function and provide novel insights into the pathophysiology of CNI side effects and involved molecular players in the DCT.

AB - Adverse effects of calcineurin inhibitors (CNI), such as hypertension, hyperkalemia, acidosis, hypomagnesemia and hypercalciuria, have been linked to dysfunction of the distal convoluted tubule (DCT). To test this, we generated a mouse model with an inducible DCT-specific deletion of the calcineurin regulatory subunit B alpha (CnB1-KO). Three weeks after CnB1 deletion, these mice exhibited hypomagnesemia and acidosis, but no hypertension, hyperkalemia or hypercalciuria. Consistent with the hypomagnesemia, CnB1-KO mice showed a downregulation of proteins implicated in DCT magnesium transport, including TRPM6, CNNM2, SLC41A3 and parvalbumin but expression of calcium channel TRPV5 in the kidney was unchanged. The abundance of the chloride/bicarbonate exchanger pendrin was increased, likely explaining the acidosis. Plasma aldosterone levels, kidney renin expression, abundance of phosphorylated sodium chloride-cotransporter and abundance of the epithelial sodium channel were similar in control and CnB1-KO mice, consistent with a normal sodium balance. Long-term potassium homeostasis was maintained in CnB1-KO mice, but in-vivo and ex-vivo experiments indicated that CnB1 contributes to acute regulation of potassium balance and sodium chloride-cotransporter. Tacrolimus treatment of control and CnB1-KO mice demonstrated that CNI-related hypomagnesemia is linked to impaired calcineurin-signaling in DCT, while hypocalciuria and hyponatremia occur independently of CnB1 in DCT. Transcriptome and proteome analyses of isolated DCTs demonstrated that CnB1 deletion impacts the expression of several DCT-specific proteins and signaling pathways. Thus, our data support a critical role of calcineurin for DCT function and provide novel insights into the pathophysiology of CNI side effects and involved molecular players in the DCT.

KW - Acidosis

KW - Animals

KW - Calcineurin/genetics

KW - Kidney Tubules, Distal

KW - Magnesium

KW - Mice

KW - Proteome/genetics

KW - Transcriptome

U2 - 10.1016/j.kint.2021.06.030

DO - 10.1016/j.kint.2021.06.030

M3 - SCORING: Journal article

C2 - 34252449

VL - 100

SP - 850

EP - 869

JO - KIDNEY INT

JF - KIDNEY INT

SN - 0085-2538

IS - 4

ER -